WuXi PharmaTech Kicks off this Year's Science Seminar Series by Welcoming Dr. Edward J.J. Grabowski

WuXi PharmaTech Kicks off this Year's Science Seminar Series by Welcoming Dr. Edward J.J. Grabowski

February 05, 2007

    SHANGHAI, China, Feb. 5 /Xinhua-PRNewswire/ -- WuXi
PharmaTech, China's leading provider of pharmaceutical
R&D outsourcing services started its 2007 Science
Seminar Series off on a big step by welcoming Dr. Edward
J.J Grabowski.  Dr. Grabowski, retired VP of Chemistry
(Process Research) at the Merck Research Laboratories, a
division of Merck & Company (NYSE: MRK), delighted
eager young scientists with his expertise and experience in
Process Research and Development.

    (Logo:
http://www.xprn.com.cn:9080/xprn/sa/200611271812.jpg )

    The WuXi PharmaTech Science Seminar Series is a monthly
program that invites top minds in the pharmaceutical
industry to share their wealth of experience and years of
expertise with the next generation of scientists. As well,
WuXi PharmaTech's scientific staff gains a new perspective
on the industry.

    Dr. Grabowski, a 39-year veteran of Merck, held
engaging lectures on Process Research and Development full
of anecdotes and insightful personal experiences from his
many years with Merck Research Laboratories.

    Dr. Grabowski recently retired as VP of chemistry
(Process Research) at the Merck Research Laboratories.
During his almost four decades in the industry, Dr.
Grabowski co-authored approximately 100 research papers,
and was a co-inventor on over 50 U.S. patents. As well, he
has been a guest lecturer to over 150 symposia and held
courses in Process Research at prestigious universities
such as the Massachusetts Institute of Technology, and the
University of Wisconsin.

    "To be the best, we must learn from the
best", commented Dr. Ge Li, Chairman and CEO of the
company. "We are honored to welcome Dr. Edward
Grabowski to share his experiences and knowledge of Process
Research Chemistry with our scientists. As a growing
company, we value the wisdom of an industry leader. Our
scientists are fortunate to learn from such a visionary
chemist," continued Dr. Li. 

    About WuXi PharmaTech Co., Ltd. 

    Founded in 2001, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company. As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, and process chemistry to service
biology, bioanalytical chemistry, and large scale GMP
manufacturing. WuXi PharmaTech assists its global partners
in shorting the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money. Currently, our client list consists of 19
of the top 20 pharmaceutical, and 8 of the top 10
biopharmaceutical companies. For more information, please
visit: http://www.pharmatechs.com .


    For more information, please contact:

     Sherry Shao
     Tel:   [phone]
     Email: [e-mail]


SOURCE  WuXi PharmaTech Co., Ltd.